ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,464.71
-0.15%
Dow Jones
39,149.91
0.04%
US Dollar vs MXN
18.13485
-1.20%
Brent Oil
84.435
-0.67%
Bitcoin
64,266.65
-0.85%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
21/06/202415:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCCTUPerception Capital Corporation II
21/06/202415:01Business WireAtara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare DiseasesNASDAQ:ATRAAtara Biotherapeutics Inc
21/06/202415:00GlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by TakedaNASDAQ:HCMHUTCHMED China Limited
21/06/202415:00GlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024TG:6IVInventiva
21/06/202415:00GlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  EU:IVAInventiva
21/06/202415:00Business WireTakeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal CancerNYSE:TAKTakeda Pharmaceutical Company Ltd
21/06/202415:00Business WirePennsylvania American Water Applies for East Dunkard Water Authority Acquisition ApprovalNYSE:AWKAmerican Water Works
21/06/202415:00GlobeNewswire Inc.In order to complete Meraki refinancing Baltic Horizon Fund requests for a waiver and bondholders consent under the bond terms and conditions
21/06/202415:00GlobeNewswire Inc.CoinShares Announces FlowBank Holdings SA Investment ImpairmentTG:3TWCoinShares International Limited
21/06/202415:00PR Newswire (Canada)Franklin Templeton Canada annonce une distribution de FNB en espècesTSX:FLCPFranklin Canadian Core Plus Fund
21/06/202415:00PR Newswire (Canada)Lysander Announces Cash Distributions for the Lysander-Canso ActivETFsTSX:PRLysander Slater Preferred Share ActivETF
21/06/202415:00PR Newswire (Canada)Franklin Templeton Canada Announces ETF Cash DistributionsTSX:FGOVFranklin Canadian Government Bond Fund
21/06/202415:00PR Newswire (US)Drivers in Chicago, Illinois, Can Get Wheel Alignment Service at McLaren Chicago
21/06/202414:57PR Newswire (Canada)Iconic Niagara Winery Château des Charmes Has Been Sold
21/06/202414:57Business WireQpiAI conclut un financement de présérie A de 6,5 millions de dollars, mené par Yournest et SIDBI Venture Capital, permettant la modélisation et le calcul de l’intelligence à l’aide d’ordinateurs quantiques
21/06/202414:56Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
21/06/202414:54Business WireFrank Zappa & the Mothers of Invention’s Wild Three-hour Concert Recorded Live at the Whisky a Go Go in 1968 out Now as Whisky a Go Go, 1968
21/06/202414:52Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
21/06/202414:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SQLSeqLL Inc
21/06/202414:50Business WireMica Nguyen Worthy of Cranfill Sumner LLP Submits First-of-its-Kind Claim to NASA Seeking Recovery From Damages Sustained From Space Debris
21/06/202414:49PR Newswire (US)Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolutionNYSE:LLYEli Lilly and Co
21/06/202414:45Business WireVertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific SessionsNASDAQ:VRTXVertex Pharmaceuticals Inc
21/06/202414:45PR Newswire (US)Use of Tirzepatide Shown to Improve Sleep Apnea and Cardiovascular Outcomes
21/06/202414:45PR Newswire (US)Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients
21/06/202414:45PR Newswire (US)Expanded FORWARD Trial Demonstrates Continued Potential for Stem Cell-Derived Islet Cell Therapy to Eliminate Need for Insulin for People with T1D
21/06/202414:44PR Newswire (US)Larsa Pippen's Innovative New Product: The Larsa Light Now Available for Purchase
21/06/202414:43GlobeNewswire Inc.Drone Nerds Expands Freefly Enterprise Solution Offerings with New Blue UAS & NDAA Compliant Drones
21/06/202414:43GlobeNewswire Inc.Standards Alliance Awards Inteleos Foundation to Expand Ultrasound Training in Kenya
21/06/202414:42PR Newswire (US)EY Announces Charles Zhang and Lynn Chen-Zhang of Zhang Financial as an Entrepreneur Of The Year® 2024 Michigan and Northwest Ohio Award Winner
21/06/202414:38GlobeNewswire Inc.OFL: Move to close the Ontario Science Centre immediately, is result of Conservative Government negligence and a failure to properly fund the services Ontarians rely on

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
NYSE
AXP
American Express
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
FX
EURMXN
Euro vs MXN
NYSE
NKE
Nike
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados